12,020 Shares in BrightSpring Health Services, Inc. $BTSG Purchased by Summit Global Investments

Summit Global Investments purchased a new stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 12,020 shares of the company’s stock, valued at approximately $682,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company acquired a new stake in BrightSpring Health Services during the 2nd quarter valued at $239,377,000. Bank of America Corp DE purchased a new position in shares of BrightSpring Health Services during the second quarter valued at $127,475,000. Bank of New York Mellon Corp acquired a new position in BrightSpring Health Services during the second quarter valued at $118,162,000. Arrowstreet Capital Limited Partnership raised its position in BrightSpring Health Services by 109.7% during the first quarter. Arrowstreet Capital Limited Partnership now owns 1,370,440 shares of the company’s stock valued at $58,394,000 after buying an additional 716,949 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its position in BrightSpring Health Services by 236.1% during the first quarter. Allspring Global Investments Holdings LLC now owns 860,134 shares of the company’s stock valued at $36,151,000 after buying an additional 604,232 shares during the period.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. BMO Capital Markets reissued an “outperform” rating on shares of BrightSpring Health Services in a research note on Friday, October 2nd. The Goldman Sachs Group reiterated a “buy” rating and issued a $90.00 target price on shares of BrightSpring Health Services in a report on Monday. Morgan Stanley increased their price target on shares of BrightSpring Health Services from $71.00 to $80.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. Raymond James Financial initiated coverage on shares of BrightSpring Health Services in a research report on Thursday, July 9th. They issued an “outperform” rating and a $80.00 price target for the company. Finally, TD Cowen raised their price target on shares of BrightSpring Health Services from $81.00 to $84.00 and gave the stock a “buy” rating in a report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, BrightSpring Health Services currently has an average rating of “Moderate Buy” and a consensus target price of $77.62.

BrightSpring Health Services News Roundup

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Strong Q3 performance and higher guidance: BrightSpring’s third-quarter earnings reportedly rose 80%, with pharmacy and home health growth driving a revenue beat and margin expansion. Management also raised its 2026 outlook and highlighted potential for continued organic growth in 2027, supported by specialty drug launches and home health gains. BrightSpring Q3 Earnings Beat on Specialty Growth, 2026 View Raised
• Positive Sentiment: Analysts raised price targets: Leerink Partners increased its target from $72 to $92 and assigned an “outperform” rating. TD Cowen raised its target from $81 to $84 and issued a “buy” rating, while Wells Fargo lifted its target from $78 to $82 and maintained an “overweight” rating. These revisions signal increased confidence in BrightSpring’s earnings growth and business momentum. Leerink Partners BrightSpring Ratings TD Cowen BrightSpring Ratings Wells Fargo BrightSpring Ratings
• Positive Sentiment: Improved consensus sentiment: Wall Street Zen upgraded BTSG to “strong-buy,” adding to the favorable analyst commentary surrounding the earnings report. Wall Street Zen Upgrades BrightSpring to Strong-Buy

BrightSpring Health Services Price Performance

Shares of NASDAQ:BTSG opened at $66.26 on Tuesday. The firm has a market cap of $13.11 billion, a price-to-earnings ratio of 35.82, a P/E/G ratio of 0.77 and a beta of 1.87. BrightSpring Health Services, Inc. has a 1 year low of $30.64 and a 1 year high of $73.75. The company has a current ratio of 1.59, a quick ratio of 1.22 and a debt-to-equity ratio of 1.06. The business has a fifty day simple moving average of $60.09 and a 200 day simple moving average of $54.68.

BrightSpring Health Services (NASDAQ:BTSG) last issued its earnings results on Friday, October 30th. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.47 by $0.07. BrightSpring Health Services had a return on equity of 16.73% and a net margin of 2.55%. The firm had revenue of $4.21 billion for the quarter, compared to the consensus estimate of $3.88 billion. The business’s revenue for the quarter was up 26.4% compared to the same quarter last year. As a group, sell-side analysts predict that BrightSpring Health Services, Inc. will post 1.64 earnings per share for the current fiscal year.

BrightSpring Health Services Profile

BrightSpring Health Services (NASDAQ:BTSG) is a Louisville, Kentucky-based provider of home- and community-based health services and pharmacy services. The company focuses on supporting individuals with complex or chronic care needs, including older adults and people with disabilities, through care delivered in homes, communities and other non-hospital settings.

Its services include home health, hospice, personal care, behavioral health, primary care, rehabilitation and community living programs.